ASSESSMENT OF DRUG-THERAPY AND HEALTH-RELATED QUALITY OF LIFE IN CANCER PATIENTS RECEIVING PHARMACEUTICAL CARE VERSUS USUAL CARE

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210809008

Enrollment

252

Registered

2021-08-09

Start date

2020-11-23

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer patients receiving chemotherapy drug therapy related quality of life pharmaceutical care cancer patients receiving chemotherapy Pormpt-qol

Interventions

Usual care, pharmaceutical care

No Intervention No treatment,Experimental Device

Control group,Study group

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients receiving treatment at the chemotherapy unit, Samutprakarn Hospital from November 2020 to Fabruary 2021. Patients receiving chemotherapy drugs at every cycle except the last cycle. 18 years old or older. Not disabled. No psychoactive symptoms. O Patients agree to participate in the study.

Exclusion criteria

Exclusion criteria: Patients referred to other hospitals Patients loss follow-up Patients death

Design outcomes

Primary

Measure	Time frame
drug therapy-related quality of life Before and after Independent t-test	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactPhantipa Sukthong

Chulalongkorn university

Phantipa.s@pharm.chula.ac.th0819228644

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026